|
Inflammatory Myofibroblastic Tumor
|
0.310 |
FusionGene
|
disease |
ORPHANET |
Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor.
|
13679433 |
2003 |
|
Inflammatory Myofibroblastic Tumor
|
0.310 |
Biomarker
|
disease |
BEFREE |
Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor.
|
13679433 |
2003 |
|
Inflammatory Myofibroblastic Tumor
|
0.310 |
FusionGene
|
disease |
ORPHANET |
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
|
12112524 |
2002 |
|
Microcephaly
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
|
30824121 |
2019 |
|
Brittle hair
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Compared to subjects with previously reported ARS-related diseases, individuals with bi-allelic CARS variants are unique in presenting with a brittle-hair-and-nail phenotype, which most likely reflects the high cysteine content in human keratins.
|
30824121 |
2019 |
|
Fragile nails
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
|
30824121 |
2019 |
|
Neurodevelopmental delay
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
|
30824121 |
2019 |
|
Alcoholic Intoxication, Chronic
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Combining evidence from the case-control study, the follow-up in families, and gene expression provided strongest support for the association of a cluster of genes on chromosome 11 (SLC22A18, PHLDA2, NAP1L4, SNORA54, CARS, and OSBPL5) with alcohol dependence.
|
20201924 |
2010 |
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Calcium measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.
|
24068962 |
2013 |
|
Calcium measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.
|
24068962 |
2013 |
|
Calcium level result
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.
|
24068962 |
2013 |
|
Longevity
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Joint influence of small-effect genetic variants on human longevity.
|
20834067 |
2010 |
|
Longevity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Joint influence of small-effect genetic variants on human longevity.
|
20834067 |
2010 |
|
Autism Spectrum Disorders
|
0.050 |
Biomarker
|
disease |
BEFREE |
After controlling for the course of regression, the CARS scores were significantly correlated with the regional efficiency of the right precuneus in the ASD-R group.
|
31562903 |
2020 |
|
Autism Spectrum Disorders
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
In the female ASD group(n = 15), CARS-TV Nonverbal communication subscale scores and RBS-R Compulsive subscale scores were seen to positively correlate with serum OXT concentrations.
|
30640053 |
2019 |
|
Autism Spectrum Disorders
|
0.050 |
Biomarker
|
disease |
BEFREE |
The diagnosis and severity of ASD for participants (N=80) was performed by DSM-5, ADIR and CARS.
|
29216607 |
2018 |
|
Autism Spectrum Disorders
|
0.050 |
Biomarker
|
disease |
BEFREE |
A total of 30 children were included.The distribution of the number of children with mild to moderate versus severe ASD was nearly equal based on CARS autism scores.
|
30031872 |
2018 |
|
Autism Spectrum Disorders
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Even though the 5-HT level was not associated with severity of behavioral CARS score, a significant negative relationship was observed for 5-HT levels and level and consistency of intellectual response and general impression in ASD children.
|
25261775 |
2015 |
|
Autistic Disorder
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Forty-one children with CdLS (23 females, 18 males) were classified as having "no autism" (n = 7; 17.1%), "mild autism" (n = 17; 41.4%), and "severe autism" (n = 17; 41.4%), using CARS scores.
|
24718998 |
2014 |
|
Autistic Disorder
|
0.040 |
Biomarker
|
disease |
BEFREE |
The boys completed probes from the Test of Early Grammatical Impairment (TEGI; Rice & Wexler, 2001), a language sample, a nonverbal IQ test (Leiter-R; Roid & Miller, 1997), a receptive vocabulary test (the Pearson Picture Vocabulary Test-Fourth Edition [PPVT-IV]; Dunn & Dunn, 2007), and a measure of autistic symptoms (the Childhood Autism Rating Scale [CARS]; Schopler, Reichler, & Renner, 2002).
|
22562829 |
2012 |
|
Autistic Disorder
|
0.040 |
Biomarker
|
disease |
BEFREE |
We have followed DSM-IV criteria and the screening for autism was carried out using CARS.
|
18597938 |
2008 |
|
Autistic Disorder
|
0.040 |
Biomarker
|
disease |
BEFREE |
The 71% (94/133) who fulfilled DSM-IV and CARS autism diagnostic criteria were included in this study.
|
10766977 |
2000 |
|
Septicemia
|
0.030 |
Biomarker
|
disease |
BEFREE |
Sepsis-3 brings a considerable shift regarding the experimental focal point: from inflammatory states (SIRS/CARS) to organ failure (single and multiple) as the decisive factor.
|
28410332 |
2017 |
|
Sepsis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Sepsis-3 brings a considerable shift regarding the experimental focal point: from inflammatory states (SIRS/CARS) to organ failure (single and multiple) as the decisive factor.
|
28410332 |
2017 |